You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pomalidomide

Showing 26 - 50 of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,

Active, not recruiting
Has Results
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Mar 28, 2022

Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Relapsed Refractory Multiple Myeloma
  • (no location specified)
Feb 6, 2023

Plasma Cell Myeloma Trial in Atlanta (Belantamab Mafodotin, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Belantamab Mafodotin
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Jul 21, 2022

Multiple Myeloma Trial in Milwaukee (Isatuximab (for run-in portion), Isatuximab (for expansion), Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Isatuximab (for run-in portion)
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Feb 18, 2022

Multiple Myeloma Trial in United States (Carfilzomib, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Atlanta, Georgia
  • +8 more
Jul 28, 2022

Relapsed/Refractory Multiple Myeloma With Pomalidomide in

Recruiting
  • Multiple Myeloma
  • Pomalidomide
  • +2 more
  • Feldkirch, Austria
  • +12 more
May 16, 2022

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Multiple Myeloma Trial (pomalidomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • pomalidomide
  • +2 more
  • (no location specified)
Jun 20, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

Active, not recruiting
Has Results
  • Plasma Cell Leukemia
  • +2 more
  • Rochester, Minnesota
  • +1 more
May 19, 2022

Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 3, 2022

CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

Active, not recruiting
Has Results
  • Central Nervous System Neoplasms
  • Medulloblastoma
  • Pomalidomide
  • Stanford, California
  • +24 more
Sep 28, 2022

Multiple Myeloma Trial in Washington, Hackensack (Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG)

Recruiting
  • Multiple Myeloma
  • Selinexor 60 MG
  • +6 more
  • Washington, District of Columbia
  • +1 more
Feb 3, 2022

Multiple Myeloma Trial (Pembrolizumab, Pomalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Sep 13, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 17, 2022

Plasma Cell Myeloma Trial in Atlanta (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 5, 2021

Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +3 more
  • Boston, Massachusetts
  • +2 more
Oct 28, 2021

Multiple Myeloma Trial in Canada, United States (Pomalidomide, Carfilzomib, dexamethasone)

Recruiting
  • Multiple Myeloma
  • Pomalidomide
  • +3 more
  • Chicago, Illinois
  • +4 more
Jan 7, 2022

Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +24 more
Dec 15, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Dexamethasone, Leflunomide, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
Jan 10, 2022

Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

Completed
  • Neurofibromatosis Type 1
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +11 more
Apr 22, 2022

Multiple Myeloma Trial (Elotuzumab, Pomalidomide)

Withdrawn
  • Multiple Myeloma
  • (no location specified)
Aug 18, 2021

Multiple Myeloma Trial (Daratumumab, Cyclophosphamide, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 8, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +5 more
Oct 28, 2021

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Bone Marrow Biopsy
  • +3 more
  • Phoenix, Arizona
  • +2 more
Jan 18, 2023